Exact Mass: 445.1649

Exact Mass Matches: 445.1649

Found 467 metabolites which its exact mass value is equals to given mass value 445.1649, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Narceine

6-(2-{6-[2-(dimethylamino)ethyl]-4-methoxy-2H-1,3-benzodioxol-5-yl}acetyl)-2,3-dimethoxybenzoic acid

C23H27NO8 (445.1737)


Narceine is found in opium poppy. Narceine is an alkaloid from Papaver somniferum (opium poppy C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist Narceine is a stilbenoid.

   

Tetrahydrofolic acid

2-{[4-({[(6S)-4-hydroxy-2-imino-5,6,7,8-tetrahydro-1H-pteridin-6-yl]methyl}amino)phenyl]formamido}pentanedioic acid

C19H23N7O6 (445.171)


Tetrahydrofolate is a soluble coenzyme (vitamin B9) that is synthesized de novo by plants and microorganisms, and absorbed from the diet by animals. It is composed of three distinct parts: a pterin ring, a p-ABA (p-aminobenzoic acid) and a polyglutamate chain with a number of residues varying between 1 and 8. Only the tetra-reduced form of the molecule serves as a coenzyme for C1 transfer reactions. In biological systems, the C1-units exist under various oxidation states and the different tetrahydrofolate derivatives constitute a family of related molecules named indistinctly under the generic term folate. (PMID 16042593). Folate is important for cells and tissues that rapidly divide. Cancer cells divide rapidly, and drugs that interfere with folate metabolism are used to treat cancer. Methotrexate is a drug often used to treat cancer because it inhibits the production of the active form, tetrahydrofolate. Unfortunately, methotrexate can be toxic, producing side effects such as inflammation in the digestive tract that make it difficult to eat normally. -- Wikipedia; Signs of folic acid deficiency are often subtle. Diarrhea, loss of appetite, and weight loss can occur. Additional signs are weakness, sore tongue, headaches, heart palpitations, irritability, and behavioral disorders. Women with folate deficiency who become pregnant are more likely to give birth to low birth weight and premature infants, and infants with neural tube defects. In adults, anemia is a sign of advanced folate deficiency. In infants and children, folate deficiency can slow growth rate. Some of these symptoms can also result from a variety of medical conditions other than folate deficiency. It is important to have a physician evaluate these symptoms so that appropriate medical care can be given. -- Wikipedia; Folinic acid is a form of folate that can help rescue or reverse the toxic effects of methotrexate. Folinic acid is not the same as folic acid. Folic acid supplements have little established role in cancer chemotherapy. There have been cases of severe adverse effects of accidental substitution of folic acid for folinic acid in patients receiving methotrexate cancer chemotherapy. It is important for anyone receiving methotrexate to follow medical advice on the use of folic or folinic acid supplements. -- Wikipedia. Low concentrations of folate, vitamin B12, or vitamin B6 may increase the level of homocysteine, an amino acid normally found in blood. There is evidence that an elevated homocysteine level is an independent risk factor for heart disease and stroke. The evidence suggests that high levels of homocysteine may damage coronary arteries or make it easier for blood clotting cells called platelets to clump together and form a clot. However, there is currently no evidence available to suggest that lowering homocysteine with vitamins will reduce your risk of heart disease. Clinical intervention trials are needed to determine whether supplementation with folic acid, vitamin B12 or vitamin B6 can lower your risk of developing coronary heart disease. -- Wikipedia. Tetrahydrofolate is a soluble coenzyme (vitamin B9) that is synthesized de novo by plants and microorganisms, and absorbed from the diet by animals. It is composed of three distinct parts: a pterin ring, a p-ABA (p-aminobenzoic acid) and a polyglutamate chain with a number of residues varying between 1 and 8. Only the tetra-reduced form of the molecule serves as a coenzyme for C1 transfer reactions. In biological systems, the C1-units exist under various oxidation states and the different tetrahydrofolate derivatives constitute a family of related molecules named indistinctly under the generic term folate. (PMID 16042593)

   
   

O-Hexanoyl-adnosine monophosphate

O-Hexanoyl-adnosine monophosphate

C16H24N5O8P (445.1362)


   

Fumiquinazoline A

Fumiquinazoline A

C24H23N5O4 (445.175)


A fumiquinazoline that consists of imidazoindole and pyrazinoquinazoline units connected by a methylene group.

   

tridihexethyl iodide

tridihexethyl iodide

C21H36INO (445.1842)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

cerdulatinib

cerdulatinib

C20H27N7O3S (445.1896)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

Tak-593

Tak-593

C23H23N7O3 (445.1862)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

glipizide

Glipizide (Glucotrol)

C21H27N5O4S (445.1784)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4274; ORIGINAL_PRECURSOR_SCAN_NO 4271 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4287; ORIGINAL_PRECURSOR_SCAN_NO 4286 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4253; ORIGINAL_PRECURSOR_SCAN_NO 4250 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4272; ORIGINAL_PRECURSOR_SCAN_NO 4269 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4267; ORIGINAL_PRECURSOR_SCAN_NO 4265 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4263; ORIGINAL_PRECURSOR_SCAN_NO 4262 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8486; ORIGINAL_PRECURSOR_SCAN_NO 8483 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8521; ORIGINAL_PRECURSOR_SCAN_NO 8519 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8531; ORIGINAL_PRECURSOR_SCAN_NO 8530 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8569; ORIGINAL_PRECURSOR_SCAN_NO 8565 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8574; ORIGINAL_PRECURSOR_SCAN_NO 8570 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8577; ORIGINAL_PRECURSOR_SCAN_NO 8573

   

Dehydroaripiprazole

7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)quinolin-2(1H)-one

C23H25Cl2N3O2 (445.1324)


Dehydroaripiprazole (OPC-14857) is an active metabolite of Aripiprazole. Aripiprazole is an antipsychotic agent and is metabolized by CYP3A4 and CYP2D6 forming mainly Dehydroaripiprazole. Dehydroaripiprazole has with antipsychotic activity equivalent to Aripiprazole[1][2][3].

   

Glipizide

N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide

C21H27N5O4S (445.1784)


Glipizide is only found in individuals that have used or taken this drug. It is an oral hypoglycemic agent which is rapidly absorbed and completely metabolized. [PubChem]Sulfonylureas likely bind to ATP-sensitive potassium-channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Depolarization stimulates calcium ion influx through voltage-sensitive calcium channels, raising intracellular concentrations of calcium ions, which induces the secretion, or exocytosis, of insulin. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents

   

Lucuminamide

2-phenyl-2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]ethanimidic acid

C19H27NO11 (445.1584)


Lucuminamide is found in fruits. Lucuminamide is a constituent of Calocarpum sapota (marmelade plum)

   

N-Oxide abiraterone sulfate

3-[2,15-dimethyl-5-(sulfooxy)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-7,13-dien-14-yl]pyridin-1-ium-1-olate

C24H31NO5S (445.1923)


N-Oxide abiraterone sulfate is a metabolite of abiraterone. Abiraterone is a drug used in castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) (prostate cancer not responding to androgen deprivation or treatment with antiandrogens). It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. (Wikipedia)

   

5,6,7,8-Tetrahydrofolic acid

2-[(4-{[(4-hydroxy-2-imino-5,6,7,8-tetrahydro-1H-pteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid

C19H23N7O6 (445.171)


Tetrahydrofolate is a soluble coenzyme (vitamin B9) that is synthesized de novo by plants and microorganisms, and absorbed from the diet by animals. It is composed of three distinct parts: a pterin ring, a p-ABA (p-aminobenzoic acid) and a polyglutamate chain with a number of residues varying between 1 and 8. Only the tetra-reduced form of the molecule serves as a coenzyme for C1 transfer reactions. In biological systems, the C1-units exist under various oxidation states and the different tetrahydrofolate derivatives constitute a family of related molecules named indistinctly under the generic term folate. (PMID 16042593)

   

Dibutyryl cyclic 3',5'-cytidine monophosphate

6-[4-(Butanoylimino)-2-hydroxy-1,4-dihydropyrimidin-1-yl]-2-hydroxy-2-oxo-hexahydro-2-furo[3,2-D][1,3,2]dioxaphosphinin-7-yl butanoic acid

C17H24N3O9P (445.125)


   

Dehydroaripiprazole

7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2-dihydroquinolin-2-one

C23H25Cl2N3O2 (445.1324)


Dehydroaripiprazole (OPC-14857) is an active metabolite of Aripiprazole. Aripiprazole is an antipsychotic agent and is metabolized by CYP3A4 and CYP2D6 forming mainly Dehydroaripiprazole. Dehydroaripiprazole has with antipsychotic activity equivalent to Aripiprazole[1][2][3].

   

Glisentide

N-(2-(4-((((Cyclopentylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide

C22H27N3O5S (445.1671)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent

   

Metopimazine

1-[3-(2-Methanesulphonyl-10H-phenothiazin-10-yl)propyl]piperidine-4-carboximidic acid

C22H27N3O3S2 (445.1494)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

O-Demethyl apixaban

1-(4-Hydroxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboximidate

C24H23N5O4 (445.175)


   

P-Hydroxyhippuryl-his-leu-OH

2-{[1-hydroxy-2-({1-hydroxy-2-[(4-hydroxyphenyl)formamido]ethylidene}amino)-3-(1H-imidazol-5-yl)propylidene]amino}-4-methylpentanoate

C21H27N5O6 (445.1961)


   

N-(4-Fluorobenzyl)-3-oxo-1,1-diphenyltetrahydro-1H-oxazolo[3,4-a]pyrazine-7(3H)-carboxamide

N-[(4-Fluorophenyl)methyl]-3-oxo-1,1-diphenyl-hexahydro-1H-[1,3]oxazolo[3,4-a]pyrazine-7-carboximidate

C26H24FN3O3 (445.1802)


   

tetrahydrofolate

(2S)-2-[(4-{[(2-amino-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid

C19H23N7O6 (445.171)


Tetrahydrofolic acid, also known as (6s)-tetrahydrofolate or (6s)-thfa, belongs to glutamic acid and derivatives class of compounds. Those are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Tetrahydrofolic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Tetrahydrofolic acid can be found in a number of food items such as malabar plum, parsnip, white lupine, and alpine sweetvetch, which makes tetrahydrofolic acid a potential biomarker for the consumption of these food products. Tetrahydrofolic acid may be a unique S.cerevisiae (yeast) metabolite. Tetrahydrofolic acid is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Tetrahydrofolate is transported across cells by receptor-mediated endocytosis where it is needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate (DrugBank). COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Fumiquinazoline B

Fumiquinazoline B

C24H23N5O4 (445.175)


   

Lycogarubin A

Lycogalic acid dimethyl ester C

C24H19N3O6 (445.1274)


   
   
   
   
   

Rhamnoerysodine

Rhamnoerysodine

C24H31NO7 (445.21)


   
   
   

Nonyl glucosinolate

Nonyl glucosinolate

C16H31NO9S2 (445.144)


Annotation level-3

   
   
   

7-Methoxycephalosporin C

7-Methoxycephalosporin C

C17H23N3O9S (445.1155)


   

(5R)-3-methyl-2(5H)furanone-(5->6)-(6S)-5,6-dihydrochelerythrine|maclekarpine A

(5R)-3-methyl-2(5H)furanone-(5->6)-(6S)-5,6-dihydrochelerythrine|maclekarpine A

C26H23NO6 (445.1525)


   
   

11-O-methylpseurotin A

11-O-methylpseurotin A

C23H27NO8 (445.1737)


   
   
   
   

CJ 17665_130073

CJ 17665_130073

C26H27N3O4 (445.2001)


   

C24H23N5O4_2H-Pyrazino[2,1-b]quinazoline-3,6(1H,4H)-dione, 1-methyl-4-[[(2S,9S,9aS)-2,3,9,9a-tetrahydro-9-hydroxy-2-methyl-3-oxo-1H-imidazo[1,2-a]indol-9-yl]methyl]-, (1S,4R)

NCGC00380614-01_C24H23N5O4_2H-Pyrazino[2,1-b]quinazoline-3,6(1H,4H)-dione, 1-methyl-4-[[(2S,9S,9aS)-2,3,9,9a-tetrahydro-9-hydroxy-2-methyl-3-oxo-1H-imidazo[1,2-a]indol-9-yl]methyl]-, (1S,4R)-

C24H23N5O4 (445.175)


   

C24H23N5O4_2H-Pyrazino[2,1-b]quinazoline-3,6(1H,4H)-dione, 1-methyl-4-[[(2S,9S,9aS)-2,3,9,9a-tetrahydro-9-hydroxy-2-methyl-3-oxo-1H-imidazo[1,2-a]indol-9-yl]methyl]-, (1S,4R)-, (Fumiquinazoline A)

NCGC00380614-01_C24H23N5O4_2H-Pyrazino[2,1-b]quinazoline-3,6(1H,4H)-dione, 1-methyl-4-[[(2S,9S,9aS)-2,3,9,9a-tetrahydro-9-hydroxy-2-methyl-3-oxo-1H-imidazo[1,2-a]indol-9-yl]methyl]-, (1S,4R)-, (Fumiquinazoline A)

C24H23N5O4 (445.175)


   
   

Metopimazine

Metopimazine

C22H27N3O3S2 (445.1494)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

tetrahydrofolic acid

L-5,6,7,8-Tetrahydrofolic acid

C19H23N7O6 (445.171)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

(6S)-5,6,7,8-tetrahydrofolate(2-)

(6S)-5,6,7,8-tetrahydrofolate(2-)

C19H23N7O6 (445.171)


   
   

Ala Cys Pro Arg

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C17H31N7O5S (445.2107)


   

Ala Cys Arg Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C17H31N7O5S (445.2107)


   

Ala Met Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C18H31N5O6S (445.1995)


   

Ala Met Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Ala Asn Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C16H27N7O8 (445.1921)


   

Ala Asn Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C16H27N7O8 (445.1921)


   

Ala Pro Cys Arg

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C17H31N7O5S (445.2107)


   

Ala Pro Met Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C18H31N5O6S (445.1995)


   

Ala Pro Gln Met

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C18H31N5O6S (445.1995)


   

Ala Pro Arg Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C17H31N7O5S (445.2107)


   

Ala Gln Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Ala Gln Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C16H27N7O8 (445.1921)


   

Ala Gln Pro Met

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C18H31N5O6S (445.1995)


   

Ala Arg Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H31N7O5S (445.2107)


   

Ala Arg Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H31N7O5S (445.2107)


   

Cys Ala Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C17H31N7O5S (445.2107)


   

Cys Ala Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C17H31N7O5S (445.2107)


   

Cys Ile Asn Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Cys Ile Pro Asn

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C18H31N5O6S (445.1995)


   

Cys Leu Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Cys Leu Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C18H31N5O6S (445.1995)


   

Cys Asn Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Cys Asn Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Cys Asn Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C18H31N5O6S (445.1995)


   

Cys Asn Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C18H31N5O6S (445.1995)


   

Cys Pro Ala Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]-5-carbamimidamidopentanoic acid

C17H31N7O5S (445.2107)


   

Cys Pro Ile Asn

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-carbamoylpropanoic acid

C18H31N5O6S (445.1995)


   

Cys Pro Leu Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-carbamoylpropanoic acid

C18H31N5O6S (445.1995)


   

Cys Pro Asn Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-methylpentanoic acid

C18H31N5O6S (445.1995)


   

Cys Pro Asn Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-4-methylpentanoic acid

C18H31N5O6S (445.1995)


   

Cys Pro Gln Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-methylbutanoic acid

C18H31N5O6S (445.1995)


   

Cys Pro Arg Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]propanoic acid

C17H31N7O5S (445.2107)


   

Cys Pro Val Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-4-carbamoylbutanoic acid

C18H31N5O6S (445.1995)


   

Cys Gln Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H31N5O6S (445.1995)


   

Cys Gln Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Cys Arg Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C17H31N7O5S (445.2107)


   

Cys Arg Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C17H31N7O5S (445.2107)


   

Cys Val Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C18H31N5O6S (445.1995)


   

Cys Val Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Asp Asn Pro Thr

(3S)-3-amino-3-{[(2S)-3-carbamoyl-1-[(2S)-2-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}propanoic acid

C17H27N5O9 (445.1809)


   

Asp Asn Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Asp Pro Asn Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C17H27N5O9 (445.1809)


   

Asp Pro Gln Ser

(3S)-3-amino-4-[(2S)-2-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C17H27N5O9 (445.1809)


   

Asp Pro Ser Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C17H27N5O9 (445.1809)


   

Asp Pro Thr Asn

(3S)-3-amino-4-[(2S)-2-{[(1S,2R)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C17H27N5O9 (445.1809)


   

Asp Gln Pro Ser

(3S)-3-amino-3-{[(2S)-4-carbamoyl-1-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamoyl}propanoic acid

C17H27N5O9 (445.1809)


   

Asp Gln Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Asp Ser Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C17H27N5O9 (445.1809)


   

Asp Ser Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Asp Thr Asn Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Asp Thr Pro Asn

(3S)-3-amino-3-{[(2S,3R)-1-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]carbamoyl}propanoic acid

C17H27N5O9 (445.1809)


   

Glu Asn Pro Ser

(4S)-4-amino-4-{[(2S)-3-carbamoyl-1-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}butanoic acid

C17H27N5O9 (445.1809)


   

Glu Asn Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carbamoylpropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Glu Pro Asn Ser

(4S)-4-amino-5-[(2S)-2-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C17H27N5O9 (445.1809)


   

Glu Pro Ser Asn

(4S)-4-amino-5-[(2S)-2-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C17H27N5O9 (445.1809)


   

Glu Ser Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Glu Ser Pro Asn

(4S)-4-amino-4-{[(2S)-1-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]carbamoyl}butanoic acid

C17H27N5O9 (445.1809)


   

Gly Asn Gln Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-4-carbamoylbutanamido]-4-carbamoylbutanoic acid

C16H27N7O8 (445.1921)


   

Gly Pro Ser Trp

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-(1H-indol-3-yl)propanoic acid

C21H27N5O6 (445.1961)


   

Gly Pro Trp Ser

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]-3-hydroxypropanoic acid

C21H27N5O6 (445.1961)


   

Gly Gln Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C16H27N7O8 (445.1921)


   

Gly Gln Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C16H27N7O8 (445.1921)


   

Gly Ser Pro Trp

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C21H27N5O6 (445.1961)


   

Gly Ser Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C21H27N5O6 (445.1961)


   

Gly Trp Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C21H27N5O6 (445.1961)


   

Gly Trp Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C21H27N5O6 (445.1961)


   

Ile Cys Asn Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Ile Cys Pro Asn

(2S)-2-{[(2S)-1-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C18H31N5O6S (445.1995)


   

Ile Asn Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Ile Asn Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Ile Pro Cys Asn

(2S)-2-[(2R)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C18H31N5O6S (445.1995)


   

Ile Pro Asn Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Leu Cys Asn Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Leu Cys Pro Asn

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C18H31N5O6S (445.1995)


   

Leu Asn Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Leu Asn Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Leu Pro Cys Asn

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C18H31N5O6S (445.1995)


   

Leu Pro Asn Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Met Ala Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C18H31N5O6S (445.1995)


   

Met Ala Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Met Pro Ala Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-carbamoylbutanoic acid

C18H31N5O6S (445.1995)


   

Met Pro Gln Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]propanoic acid

C18H31N5O6S (445.1995)


   

Met Gln Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]propanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Met Gln Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C18H31N5O6S (445.1995)


   

Asn Ala Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C16H27N7O8 (445.1921)


   

Asn Ala Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C16H27N7O8 (445.1921)


   

Asn Cys Ile Pro

(2S)-1-[(2S,3S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Asn Cys Leu Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Asn Cys Pro Ile

(2S,3S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C18H31N5O6S (445.1995)


   

Asn Cys Pro Leu

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C18H31N5O6S (445.1995)


   

Asn Asp Pro Thr

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-4-[(2S)-2-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C17H27N5O9 (445.1809)


   

Asn Asp Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Asn Glu Pro Ser

(4S)-4-[(2S)-2-amino-3-carbamoylpropanamido]-5-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C17H27N5O9 (445.1809)


   

Asn Glu Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carboxybutanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Asn Gly Gln Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-4-carbamoylbutanamido]-4-carbamoylbutanoic acid

C16H27N7O8 (445.1921)


   

Asn Ile Cys Pro

(2S)-1-[(2R)-2-[(2S,3S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylpentanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Asn Ile Pro Cys

(2R)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Asn Leu Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-methylpentanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Asn Leu Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Asn Asn Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]propanamido]-4-carbamoylbutanoic acid

C16H27N7O8 (445.1921)


   

Asn Asn Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]propanoic acid

C16H27N7O8 (445.1921)


   

Asn Pro Cys Ile

(2S,3S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-methylpentanoic acid

C18H31N5O6S (445.1995)


   

Asn Pro Cys Leu

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-4-methylpentanoic acid

C18H31N5O6S (445.1995)


   

Asn Pro Asp Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]-3-hydroxybutanoic acid

C17H27N5O9 (445.1809)


   

Asn Pro Glu Ser

(4S)-4-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C17H27N5O9 (445.1809)


   

Asn Pro Ile Cys

(2R)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Asn Pro Leu Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Asn Pro Ser Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]pentanedioic acid

C17H27N5O9 (445.1809)


   

Asn Pro Thr Asp

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]butanedioic acid

C17H27N5O9 (445.1809)


   

Asn Gln Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]propanamido]-3-carbamoylpropanoic acid

C16H27N7O8 (445.1921)


   

Asn Gln Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]acetamido}-4-carbamoylbutanoic acid

C16H27N7O8 (445.1921)


   

Asn Gln Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]propanoic acid

C16H27N7O8 (445.1921)


   

Asn Gln Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]-4-carbamoylbutanamido]acetic acid

C16H27N7O8 (445.1921)


   

Asn Ser Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Asn Ser Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C17H27N5O9 (445.1809)


   

Asn Thr Asp Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Asn Thr Pro Asp

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C17H27N5O9 (445.1809)


   

Pro Ala Cys Arg

(2S)-5-carbamimidamido-2-[(2R)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]pentanoic acid

C17H31N7O5S (445.2107)


   

Pro Ala Met Gln

(2S)-4-carbamoyl-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]butanoic acid

C18H31N5O6S (445.1995)


   

Pro Ala Gln Met

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]-4-(methylsulfanyl)butanoic acid

C18H31N5O6S (445.1995)


   

Pro Ala Arg Cys

(2R)-2-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]-3-sulfanylpropanoic acid

C17H31N7O5S (445.2107)


   

Pro Cys Ala Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]pentanoic acid

C17H31N7O5S (445.2107)


   

Pro Cys Ile Asn

(2S)-3-carbamoyl-2-[(2S,3S)-3-methyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]pentanamido]propanoic acid

C18H31N5O6S (445.1995)


   

Pro Cys Leu Asn

(2S)-3-carbamoyl-2-[(2S)-4-methyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]pentanamido]propanoic acid

C18H31N5O6S (445.1995)


   

Pro Cys Asn Ile

(2S,3S)-2-[(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]-3-methylpentanoic acid

C18H31N5O6S (445.1995)


   

Pro Cys Asn Leu

(2S)-2-[(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]-4-methylpentanoic acid

C18H31N5O6S (445.1995)


   

Pro Cys Gln Val

(2S)-2-[(2S)-4-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]butanamido]-3-methylbutanoic acid

C18H31N5O6S (445.1995)


   

Pro Cys Arg Ala

(2S)-2-[(2S)-5-carbamimidamido-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]pentanamido]propanoic acid

C17H31N7O5S (445.2107)


   

Pro Cys Val Gln

(2S)-4-carbamoyl-2-[(2S)-3-methyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]butanamido]butanoic acid

C18H31N5O6S (445.1995)


   

Pro Asp Asn Thr

(2S,3R)-2-[(2S)-3-carbamoyl-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-3-hydroxybutanoic acid

C17H27N5O9 (445.1809)


   

Pro Asp Gln Ser

(3S)-3-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C17H27N5O9 (445.1809)


   

Pro Asp Ser Gln

(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxypropanamido]butanoic acid

C17H27N5O9 (445.1809)


   

Pro Asp Thr Asn

(3S)-3-{[(1S,2R)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C17H27N5O9 (445.1809)


   

Pro Glu Asn Ser

(4S)-4-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C17H27N5O9 (445.1809)


   

Pro Glu Ser Asn

(4S)-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C17H27N5O9 (445.1809)


   

Pro Gly Ser Trp

(2S)-2-[(2S)-3-hydroxy-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]-3-(1H-indol-3-yl)propanoic acid

C21H27N5O6 (445.1961)


   

Pro Gly Trp Ser

(2S)-3-hydroxy-2-[(2S)-3-(1H-indol-3-yl)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]propanoic acid

C21H27N5O6 (445.1961)


   

Pro Ile Cys Asn

(2S)-3-carbamoyl-2-[(2R)-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-sulfanylpropanamido]propanoic acid

C18H31N5O6S (445.1995)


   

Pro Ile Asn Cys

(2R)-2-[(2S)-3-carbamoyl-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Pro Leu Cys Asn

(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-sulfanylpropanamido]propanoic acid

C18H31N5O6S (445.1995)


   

Pro Leu Asn Cys

(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Pro Met Ala Gln

(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]butanoic acid

C18H31N5O6S (445.1995)


   

Pro Met Gln Ala

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]propanoic acid

C18H31N5O6S (445.1995)


   

Pro Asn Cys Ile

(2S,3S)-2-[(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]-3-methylpentanoic acid

C18H31N5O6S (445.1995)


   

Pro Asn Cys Leu

(2S)-2-[(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]-4-methylpentanoic acid

C18H31N5O6S (445.1995)


   

Pro Asn Asp Thr

(2S,3R)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-carboxypropanamido]-3-hydroxybutanoic acid

C17H27N5O9 (445.1809)


   

Pro Asn Glu Ser

(4S)-4-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C17H27N5O9 (445.1809)


   

Pro Asn Ile Cys

(2R)-2-[(2S,3S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylpentanamido]-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Pro Asn Leu Cys

(2R)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-methylpentanamido]-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Pro Asn Ser Glu

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxypropanamido]pentanedioic acid

C17H27N5O9 (445.1809)


   

Pro Asn Thr Asp

(2S)-2-[(2S,3R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxybutanamido]butanedioic acid

C17H27N5O9 (445.1809)


   

Pro Gln Ala Met

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C18H31N5O6S (445.1995)


   

Pro Gln Cys Val

(2S)-2-[(2R)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

C18H31N5O6S (445.1995)


   

Pro Gln Asp Ser

(3S)-3-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C17H27N5O9 (445.1809)


   

Pro Gln Met Ala

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C18H31N5O6S (445.1995)


   

Pro Gln Ser Asp

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-hydroxypropanamido]butanedioic acid

C17H27N5O9 (445.1809)


   

Pro Gln Val Cys

(2R)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Pro Arg Ala Cys

(2R)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]-3-sulfanylpropanoic acid

C17H31N7O5S (445.2107)


   

Pro Arg Cys Ala

(2S)-2-[(2R)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-sulfanylpropanamido]propanoic acid

C17H31N7O5S (445.2107)


   

Pro Ser Asp Gln

(2S)-4-carbamoyl-2-[(2S)-3-carboxy-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanoic acid

C17H27N5O9 (445.1809)


   

Pro Ser Glu Asn

(4S)-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-4-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanoic acid

C17H27N5O9 (445.1809)


   

Pro Ser Gly Trp

(2S)-2-{2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C21H27N5O6 (445.1961)


   

Pro Ser Asn Glu

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]pentanedioic acid

C17H27N5O9 (445.1809)


   

Pro Ser Gln Asp

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]butanedioic acid

C17H27N5O9 (445.1809)


   

Pro Ser Trp Gly

2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C21H27N5O6 (445.1961)


   

Pro Thr Asp Asn

(3S)-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-3-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanoic acid

C17H27N5O9 (445.1809)


   

Pro Thr Asn Asp

(2S)-2-[(2S)-3-carbamoyl-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]butanedioic acid

C17H27N5O9 (445.1809)


   

Pro Val Cys Gln

(2S)-4-carbamoyl-2-[(2R)-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-sulfanylpropanamido]butanoic acid

C18H31N5O6S (445.1995)


   

Pro Val Gln Cys

(2R)-2-[(2S)-4-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Pro Trp Gly Ser

(2S)-3-hydroxy-2-{2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}propanoic acid

C21H27N5O6 (445.1961)


   

Pro Trp Ser Gly

2-[(2S)-3-hydroxy-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]acetic acid

C21H27N5O6 (445.1961)


   

Gln Ala Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Gln Ala Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C16H27N7O8 (445.1921)


   

Gln Ala Pro Met

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C18H31N5O6S (445.1995)


   

Gln Cys Pro Val

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H31N5O6S (445.1995)


   

Gln Cys Val Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Gln Asp Pro Ser

(3S)-3-[(2S)-2-amino-4-carbamoylbutanamido]-4-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C17H27N5O9 (445.1809)


   

Gln Asp Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Gln Gly Asn Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C16H27N7O8 (445.1921)


   

Gln Gly Gln Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C16H27N7O8 (445.1921)


   

Gln Met Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]propanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Gln Met Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C18H31N5O6S (445.1995)


   

Gln Asn Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]propanamido]-3-carbamoylpropanoic acid

C16H27N7O8 (445.1921)


   

Gln Asn Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]acetamido}-4-carbamoylbutanoic acid

C16H27N7O8 (445.1921)


   

Gln Asn Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]propanoic acid

C16H27N7O8 (445.1921)


   

Gln Asn Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]acetic acid

C16H27N7O8 (445.1921)


   

Gln Pro Ala Met

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-(methylsulfanyl)butanoic acid

C18H31N5O6S (445.1995)


   

Gln Pro Cys Val

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-methylbutanoic acid

C18H31N5O6S (445.1995)


   

Gln Pro Asp Ser

(3S)-3-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C17H27N5O9 (445.1809)


   

Gln Pro Met Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]propanoic acid

C18H31N5O6S (445.1995)


   

Gln Pro Ser Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]butanedioic acid

C17H27N5O9 (445.1809)


   

Gln Pro Val Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Gln Gln Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carbamoylbutanamido]acetamido}-3-carbamoylpropanoic acid

C16H27N7O8 (445.1921)


   

Gln Gln Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]acetic acid

C16H27N7O8 (445.1921)


   

Gln Ser Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Gln Ser Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C17H27N5O9 (445.1809)


   

Gln Val Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Gln Val Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Arg Ala Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H31N7O5S (445.2107)


   

Arg Ala Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H31N7O5S (445.2107)


   

Arg Cys Ala Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C17H31N7O5S (445.2107)


   

Arg Cys Pro Ala

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C17H31N7O5S (445.2107)


   

Arg Pro Ala Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-sulfanylpropanoic acid

C17H31N7O5S (445.2107)


   

Arg Pro Cys Ala

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]propanoic acid

C17H31N7O5S (445.2107)


   

Ser Asp Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C17H27N5O9 (445.1809)


   

Ser Asp Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Ser Glu Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carboxybutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Ser Glu Pro Asn

(4S)-4-[(2S)-2-amino-3-hydroxypropanamido]-5-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C17H27N5O9 (445.1809)


   

Ser Gly Pro Trp

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-hydroxypropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C21H27N5O6 (445.1961)


   

Ser Gly Trp Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C21H27N5O6 (445.1961)


   

Ser Asn Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Ser Asn Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C17H27N5O9 (445.1809)


   

Ser Pro Asp Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]-4-carbamoylbutanoic acid

C17H27N5O9 (445.1809)


   

Ser Pro Glu Asn

(4S)-4-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C17H27N5O9 (445.1809)


   

Ser Pro Gly Trp

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-(1H-indol-3-yl)propanoic acid

C21H27N5O6 (445.1961)


   

Ser Pro Asn Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]pentanedioic acid

C17H27N5O9 (445.1809)


   

Ser Pro Gln Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]butanedioic acid

C17H27N5O9 (445.1809)


   

Ser Pro Trp Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]acetic acid

C21H27N5O6 (445.1961)


   

Ser Gln Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Ser Gln Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C17H27N5O9 (445.1809)


   

Ser Trp Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-indol-3-yl)propanamido]acetyl}pyrrolidine-2-carboxylic acid

C21H27N5O6 (445.1961)


   

Ser Trp Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}acetic acid

C21H27N5O6 (445.1961)


   

Thr Asp Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carboxypropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Thr Asp Pro Asn

(3S)-3-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C17H27N5O9 (445.1809)


   

Thr Asn Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O9 (445.1809)


   

Thr Asn Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C17H27N5O9 (445.1809)


   

Thr Pro Asp Asn

(3S)-3-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C17H27N5O9 (445.1809)


   

Thr Pro Asn Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]butanedioic acid

C17H27N5O9 (445.1809)


   

Val Cys Pro Gln

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C18H31N5O6S (445.1995)


   

Val Cys Gln Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Val Pro Cys Gln

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C18H31N5O6S (445.1995)


   

Val Pro Gln Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Val Gln Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O6S (445.1995)


   

Val Gln Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C18H31N5O6S (445.1995)


   

Trp Gly Pro Ser

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetyl}pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C21H27N5O6 (445.1961)


   

Trp Gly Ser Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C21H27N5O6 (445.1961)


   

Trp Pro Gly Ser

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-hydroxypropanoic acid

C21H27N5O6 (445.1961)


   

Trp Pro Ser Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]acetic acid

C21H27N5O6 (445.1961)


   

Trp Ser Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-hydroxypropanamido]acetyl}pyrrolidine-2-carboxylic acid

C21H27N5O6 (445.1961)


   

Trp Ser Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetic acid

C21H27N5O6 (445.1961)


   

p-Hydroxytriamterene glucuronide

p-Hydroxytriamterene glucuronide

C18H19N7O7 (445.1346)


   

PC(6:2/6:2)

3,5,9-Trioxa-4-phosphapentadeca-11,13-dien-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-2,4-hexadienyl)oxy]-, inner salt, 4-oxide, (R)-

C20H32NO8P (445.1865)


   

TyrMe-Lys-OH

(S)-7-amino-2-(3-(4-methoxyphenethoxy)-4-nitrobenzamido)heptanoic acid

C22H27N3O7 (445.1849)


   

O-hexanoyl-adenosine monophosphate

O-hexanoyl-adenosine monophosphate

C16H24N5O8P (445.1362)


   

Lucuminamide

2-phenyl-2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]acetamide

C19H27NO11 (445.1584)


   

Tauro-18-carboxy-19,20-dinor-LTB

5S,12R-dihydroxy-18-oxo-18-(2-sulfoethylamino)octadeca-6Z,8E,10E,14Z-tetraenoic acid

C20H31NO8S (445.177)


   

AMP 6:0

O-hexanoyl-adenosine monophosphate

C16H24N5O8P (445.1362)


   

icos#3

9-(3R-hydroxy-5R-O-(1H-indol-3-ylcarbonyl)-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-nonenoic acid

C24H31NO7 (445.21)


A 4-O-(1H-indol-3-ylcarbonyl)ascaroside derived from (2E)-9-hydroxynon-2-enoic acid. It is a metabolite of the nematode Caenorhabditis elegans.

   

PC 12:4

1,2-di-(2E,4E-hexadienoyl)-sn-glycero-3-phosphocholine

C20H32NO8P (445.1865)


   

[(1S)-1-[[(2-Fluoro-6-nitrobenzoyl)phenylamino]carbonyl]propyl]carbamic acid 1,1-dimethylethyl ester

[(1S)-1-[[(2-Fluoro-6-nitrobenzoyl)phenylamino]carbonyl]propyl]carbamic acid 1,1-dimethylethyl ester

C22H24FN3O6 (445.1649)


   

3,4-Dimethoxy-N-[3-(1,2,3,4-tetrahydro-7-isoquinolinylcarbamoyl)b enzyl]benzamide

3,4-Dimethoxy-N-[3-(1,2,3,4-tetrahydro-7-isoquinolinylcarbamoyl)b enzyl]benzamide

C26H27N3O4 (445.2001)


   

magnesium 1,4-bis(2-ethylhexyl) 2-sulphonatosuccinate

magnesium 1,4-bis(2-ethylhexyl) 2-sulphonatosuccinate

C20H37MgO7S (445.211)


   

4-phenyl-2-(piperazin-1-yl)thiazole

4-phenyl-2-(piperazin-1-yl)thiazole

C27H27NO3S (445.1712)


   

N4-BENZOYL-5-O-TERT-BUTYLDIMETHYLSILYL-2-DEOXYCYTIDINE

N4-BENZOYL-5-O-TERT-BUTYLDIMETHYLSILYL-2-DEOXYCYTIDINE

C22H31N3O5Si (445.2033)


5-O-TBDMS-N4-Benzoyl-2-deoxycytidine is a modified nucleoside. 5-O-TBDMS-N4-Benzoyl-2-deoxycytidine can be used in the synthesis of deoxyribonucleic acid or nucleic acid.

   

Paroxetine maleate

Paroxetine maleate

C23H24FNO7 (445.1537)


D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065690 - Cytochrome P-450 CYP2D6 Inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D049990 - Membrane Transport Modulators

   

1-Butanone,1-(4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]-1-piperidinyl]-,hydrochloride (1:1)

1-Butanone,1-(4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]-1-piperidinyl]-,hydrochloride (1:1)

C22H24ClF4NO2 (445.1432)


   

N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-6-methylpyrazine-2-carboxamide

N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-6-methylpyrazine-2-carboxamide

C21H27N5O4S (445.1784)


   

Thiazolidine, 2-(2,3-dihydro-1H-phenalen-6-yl)-3-(1-naphthalenylsulfonyl)- (9CI)

Thiazolidine, 2-(2,3-dihydro-1H-phenalen-6-yl)-3-(1-naphthalenylsulfonyl)- (9CI)

C26H23NO2S2 (445.117)


   

6-amino-4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-ethoxyquinoline-3-carbonitrile

6-amino-4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-ethoxyquinoline-3-carbonitrile

C24H20ClN5O2 (445.1305)


   
   
   
   

O-Demethyl apixaban

O-Desmethyl apixaban

C24H23N5O4 (445.175)


   
   

3-(5-[(FLUOREN-9-YLMETHOXY)CARBONYLAMINO]PENTYLOXY)BENZOIC ACID

3-(5-[(FLUOREN-9-YLMETHOXY)CARBONYLAMINO]PENTYLOXY)BENZOIC ACID

C27H27NO5 (445.1889)


   

Thiopropazate

Thiopropazate

C23H28ClN3O2S (445.1591)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   
   

Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(4-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)

Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(4-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)

C25H27N5OS (445.1936)


   

Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)

Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)

C25H27N5OS (445.1936)


   

Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(2-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)

Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(2-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)

C25H27N5OS (445.1936)


   

Mono-POC Isopropyl Tenofovir

Mono-POC Isopropyl Tenofovir

C17H28N5O7P (445.1726)


   

Thiazol-5-ylmethyl (2R,5R)-5-amino-1,6-diphenylhexan-2-ylcarbamate hydrochloride

Thiazol-5-ylmethyl (2R,5R)-5-amino-1,6-diphenylhexan-2-ylcarbamate hydrochloride

C23H28ClN3O2S (445.1591)


   

Z-Gly-Gly-Phe-chloromethylketone

Z-Gly-Gly-Phe-chloromethylketone

C22H24ClN3O5 (445.1404)


   

Fmoc-N-Me-Thr(Bzl)-OH

Fmoc-N-Me-Thr(Bzl)-OH

C27H27NO5 (445.1889)


   

Fmoc-Asp-Obzl

Fmoc-Asp-Obzl

C26H23NO6 (445.1525)


   

Quetiapine D4 hemifumarate

Quetiapine D4 hemifumarate

C23H23D4N3O4S (445.1973)


   

Selonsertib

Selonsertib(GS-4997)

C24H24FN7O (445.2026)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

   

(2S,5S)-1-(4-(tert-butyl)phenyl)-2,5-bis(4-nitrophenyl)pyrrolidine

(2S,5S)-1-(4-(tert-butyl)phenyl)-2,5-bis(4-nitrophenyl)pyrrolidine

C26H27N3O4 (445.2001)


   

Fmoc-Asp(OBzl)-OH

Fmoc-Asp(OBzl)-OH

C26H23NO6 (445.1525)


   

Pyr-Pro-Val-pNA trifluoroacetate salt

Pyr-Pro-Val-pNA trifluoroacetate salt

C21H27N5O6 (445.1961)


   

Fmoc-D-phenylglycine(4-OtBu)

Fmoc-D-phenylglycine(4-OtBu)

C27H27NO5 (445.1889)


   

2-[[Methyl[(3S)-3-(1-naphthalenyloxy)-3-(2-thienyl)propyl]amino]carbonyl]benzoic Acid

2-[[Methyl[(3S)-3-(1-naphthalenyloxy)-3-(2-thienyl)propyl]amino]carbonyl]benzoic Acid

C26H23NO4S (445.1348)


   
   

Benexate Hydrochloride

Benexate Hydrochloride

C23H28ClN3O4 (445.1768)


   

Fmoc-D-Aph(Cbm)-OH

Fmoc-D-Aph(Cbm)-OH

C25H23N3O5 (445.1638)


   

Loxapine succinate

Loxapine succinate

C22H24ClN3O5 (445.1404)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Loxapine succinate is an orally active dopamine inhibitor, 5-HT receptor antagonist and also a dibenzoxazepine anti-psychotic agent. Loxapine can also suppresses bacterial efflux pump activity and inhibit intracellular multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium in macrophages[1][4][6].

   

4-[4-[4-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine

4-[4-[4-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine

C21H19F4N7 (445.1638)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor

   

(1s,6r)-3-{[3-(Trifluoromethyl)-5,6-Dihydro[1,2,4]triazolo[4,3-A]pyrazin-7(8h)-Yl]carbonyl}-6-(2,4,5-Trifluorophenyl)cyclohex-3-En-1-Amine

(1s,6r)-3-{[3-(Trifluoromethyl)-5,6-Dihydro[1,2,4]triazolo[4,3-A]pyrazin-7(8h)-Yl]carbonyl}-6-(2,4,5-Trifluorophenyl)cyclohex-3-En-1-Amine

C19H17F6N5O (445.1337)


D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

   

Posenacaftor

Posenacaftor

C27H27NO5 (445.1889)


C87006 - Pharmacological Chaperone

   

Cerlapirdine hydrochloride

Cerlapirdine hydrochloride

C22H24ClN3O3S (445.1227)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist

   

N-(4-Fluorobenzyl)-3-oxo-1,1-diphenyltetrahydro-1H-oxazolo[3,4-a]pyrazine-7(3H)-carboxamide

N-(4-Fluorobenzyl)-3-oxo-1,1-diphenyltetrahydro-1H-oxazolo[3,4-a]pyrazine-7(3H)-carboxamide

C26H24FN3O3 (445.1802)


D000890 - Anti-Infective Agents > D023303 - Oxazolidinones SHA 68 is a potent and selective non-peptide neuropeptide S receptor (NPSR) antagonist with IC50s of 22.0 and 23.8 nM for NPSR Asn107 and NPSR Ile107, respectively. SHA 68 has limited the blood-brain barrier (BBB) penetration and the activity in neuralgia[1][2].

   

N4 2-O-Dibutyrylcytidine 3

N4 2-O-Dibutyrylcytidine 3

C17H24N3O9P (445.125)


   

4-[(4Z)-4-[[5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl]methylidene]-3-methyl-5-oxopyrazol-1-yl]benzoic acid

4-[(4Z)-4-[[5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl]methylidene]-3-methyl-5-oxopyrazol-1-yl]benzoic acid

C24H19N3O6 (445.1274)


   

(2E)-9-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}non-2-enoic acid

(2E)-9-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}non-2-enoic acid

C24H31NO7 (445.21)


   

N-(9-ethyl-3-carbazolyl)-2-[[4-ethyl-5-(2-furanyl)-1,2,4-triazol-3-yl]thio]acetamide

N-(9-ethyl-3-carbazolyl)-2-[[4-ethyl-5-(2-furanyl)-1,2,4-triazol-3-yl]thio]acetamide

C24H23N5O2S (445.1572)


   

(2E,8R)-8-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}non-2-enoic acid

(2E,8R)-8-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}non-2-enoic acid

C24H31NO7 (445.21)


   

4-(2-Aminoethoxy)-N-(3-Chloro-2-Ethoxy-5-Piperidin-1-Ylphenyl)-3,5-Dimethylbenzamide

4-(2-Aminoethoxy)-N-(3-Chloro-2-Ethoxy-5-Piperidin-1-Ylphenyl)-3,5-Dimethylbenzamide

C24H32ClN3O3 (445.2132)


   

1-((1R)-1-(Hydroxymethyl)-3-{6-[(3-phenylpropanoyl)amino]-1H-indol-1-YL}propyl)-1H-imidazole-4-carboxamide

1-((1R)-1-(Hydroxymethyl)-3-{6-[(3-phenylpropanoyl)amino]-1H-indol-1-YL}propyl)-1H-imidazole-4-carboxamide

C25H27N5O3 (445.2114)


   

(S)-2-(Phosphonoxy)caproyl-L-leucyl-P-nitroanilide

(S)-2-(Phosphonoxy)caproyl-L-leucyl-P-nitroanilide

C18H28N3O8P (445.1614)


   

N-[4-Chloro-3-(pyridin-3-yloxymethyl)-phenyl]-3-fluoro-

N-[4-Chloro-3-(pyridin-3-yloxymethyl)-phenyl]-3-fluoro-

C23H25ClFN3O3 (445.1568)


   

Glisentide

N-[2-[4-(cyclopentylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide

C22H27N3O5S (445.1671)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent

   

Narcein

6-[2-[6-(2-dimethylaminoethyl)-4-methoxy-1,3-benzodioxol-5-yl]-1-oxoethyl]-2,3-dimethoxybenzoic acid

C23H27NO8 (445.1737)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   
   

N-coumaroyl tyramine-4-O-beta-D-glucoside

N-coumaroyl tyramine-4-O-beta-D-glucoside

C23H27NO8 (445.1737)


   

N-coumaroyl tyramine 4-O-beta-D-glucoside

N-coumaroyl tyramine 4-O-beta-D-glucoside

C23H27NO8 (445.1737)


   

(6S)-Tetrahydrofolic acid

5,6,7,8-Tetrahydrofolic acid

C19H23N7O6 (445.171)


   

[10,13-dimethyl-17-(1-oxidopyridin-1-ium-3-yl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate

[10,13-dimethyl-17-(1-oxidopyridin-1-ium-3-yl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate

C24H31NO5S (445.1923)


   

5,6,7,8-Tetrahydrofolic acid

5,6,7,8-Tetrahydrofolic acid

C19H23N7O6 (445.171)


   

Avrainvillamide

Avrainvillamide

C26H27N3O4 (445.2001)


   

N-[4,6-bis(4-morpholinyl)-1,3,5-triazin-2-yl]-2-(methylthio)-1,3-benzothiazol-6-amine

N-[4,6-bis(4-morpholinyl)-1,3,5-triazin-2-yl]-2-(methylthio)-1,3-benzothiazol-6-amine

C19H23N7O2S2 (445.1355)


   

N-(2,3-dihydro-1H-inden-5-yl)-2-[[3-(2-fluorophenyl)-4-oxo-2-quinazolinyl]thio]acetamide

N-(2,3-dihydro-1H-inden-5-yl)-2-[[3-(2-fluorophenyl)-4-oxo-2-quinazolinyl]thio]acetamide

C25H20FN3O2S (445.126)


   

N-(2,3-dihydro-1H-inden-5-yl)-2-[(6-fluoro-4-oxo-3-phenyl-2-quinazolinyl)thio]acetamide

N-(2,3-dihydro-1H-inden-5-yl)-2-[(6-fluoro-4-oxo-3-phenyl-2-quinazolinyl)thio]acetamide

C25H20FN3O2S (445.126)


   

N-(2,3-dihydro-1H-inden-5-yl)-2-[(5-fluoro-4-oxo-3-phenyl-2-quinazolinyl)thio]acetamide

N-(2,3-dihydro-1H-inden-5-yl)-2-[(5-fluoro-4-oxo-3-phenyl-2-quinazolinyl)thio]acetamide

C25H20FN3O2S (445.126)


   

estrone 3-O-(beta-D-glucuronate)

estrone 3-O-(beta-D-glucuronate)

C24H29O8- (445.1862)


   
   

O-(pantetheine-4-phosphoryl)serine

O-(pantetheine-4-phosphoryl)serine

C14H28N3O9PS (445.1284)


A serine derivative in which L-serine is substituted on oxygen by a pantetheine 4-phosphate group.

   

2-[[5-[(2-fluorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-N-[(2-furanylmethylamino)-oxomethyl]acetamide

2-[[5-[(2-fluorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-N-[(2-furanylmethylamino)-oxomethyl]acetamide

C20H20FN5O4S (445.122)


   

2-Cyano-2-[3-[4-(phenylmethyl)-1-piperazinyl]-2-quinoxalinyl]acetic acid 2-methoxyethyl ester

2-Cyano-2-[3-[4-(phenylmethyl)-1-piperazinyl]-2-quinoxalinyl]acetic acid 2-methoxyethyl ester

C25H27N5O3 (445.2114)


   

1-(1-tert-butyl-5-tetrazolyl)-N-[(4-chlorophenyl)methyl]-N-(2-oxolanylmethyl)-1-thiophen-2-ylmethanamine

1-(1-tert-butyl-5-tetrazolyl)-N-[(4-chlorophenyl)methyl]-N-(2-oxolanylmethyl)-1-thiophen-2-ylmethanamine

C22H28ClN5OS (445.1703)


   

2-(2,4-Dimethoxyphenyl)-5-methyl-4-[[4-(4-quinazolinyl)-1-piperazinyl]methyl]oxazole

2-(2,4-Dimethoxyphenyl)-5-methyl-4-[[4-(4-quinazolinyl)-1-piperazinyl]methyl]oxazole

C25H27N5O3 (445.2114)


   

5-(6,7-diethoxy-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)-N-(2-furanylmethyl)pentanamide

5-(6,7-diethoxy-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)-N-(2-furanylmethyl)pentanamide

C22H27N3O5S (445.1671)


   

2-{[4-(1,3-Benzodioxol-5-ylmethyl)piperazin-1-yl]carbonyl}-7-methoxyfuro[2,3-b]quinoline

2-{[4-(1,3-Benzodioxol-5-ylmethyl)piperazin-1-yl]carbonyl}-7-methoxyfuro[2,3-b]quinoline

C25H23N3O5 (445.1638)


   

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(2,5-dimethylphenyl)sulfonyl-1-piperazinyl]acetamide

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(2,5-dimethylphenyl)sulfonyl-1-piperazinyl]acetamide

C22H27N3O5S (445.1671)


   

[2-[(3-cyanothiophen-2-yl)amino]-2-oxoethyl] (2S)-2-[(3,5-dimethoxybenzoyl)amino]-3-methylbutanoate

[2-[(3-cyanothiophen-2-yl)amino]-2-oxoethyl] (2S)-2-[(3,5-dimethoxybenzoyl)amino]-3-methylbutanoate

C21H23N3O6S (445.1307)


   

[5-[2-(3,4-Dimethoxyphenyl)quinolin-4-yl]-1,3,4-oxadiazol-2-yl]methyl 2-methylcyclopropane-1-carboxylate

[5-[2-(3,4-Dimethoxyphenyl)quinolin-4-yl]-1,3,4-oxadiazol-2-yl]methyl 2-methylcyclopropane-1-carboxylate

C25H23N3O5 (445.1638)


   

6-N-(furan-2-ylmethyl)-4-N-(4-methoxyphenyl)-2-N-[(E)-(4-methoxyphenyl)methylideneamino]-1,3,5-triazine-2,4,6-triamine

6-N-(furan-2-ylmethyl)-4-N-(4-methoxyphenyl)-2-N-[(E)-(4-methoxyphenyl)methylideneamino]-1,3,5-triazine-2,4,6-triamine

C23H23N7O3 (445.1862)


   

2-(3-Chlorophenyl)-9-[4-(2-pyrazinyl)-1-piperazinyl]-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline

2-(3-Chlorophenyl)-9-[4-(2-pyrazinyl)-1-piperazinyl]-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline

C24H24ClN7 (445.1782)


   

1-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-3-(2-methoxyphenyl)-1-(3-pyridinylmethyl)thiourea

1-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-3-(2-methoxyphenyl)-1-(3-pyridinylmethyl)thiourea

C25H27N5OS (445.1936)


   

N-[(E)-[3-(1-Benzofuran-2-yl)-1-phenylpyrazol-4-yl]methylideneamino]-1H-indole-3-carboxamide

N-[(E)-[3-(1-Benzofuran-2-yl)-1-phenylpyrazol-4-yl]methylideneamino]-1H-indole-3-carboxamide

C27H19N5O2 (445.1539)


   

N-[(E)-(4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ylidene)amino]benzamide

N-[(E)-(4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ylidene)amino]benzamide

C26H27N3O4 (445.2001)


   

1-epijosephinine Trifluoroacetic acid

1-epijosephinine Trifluoroacetic acid

C20H22F3NO7 (445.1348)


A natural product found in Crinum asiaticum var. sinicum.

   

N-Oxide abiraterone sulfate

N-Oxide abiraterone sulfate

C24H31NO5S (445.1923)


   

8-methoxy-3-[(E)-[4-methoxy-3-(1-pyrrolidinylmethyl)phenyl]methylideneamino]-2-methyl-5H-pyrimido[5,4-b]indol-4-one

8-methoxy-3-[(E)-[4-methoxy-3-(1-pyrrolidinylmethyl)phenyl]methylideneamino]-2-methyl-5H-pyrimido[5,4-b]indol-4-one

C25H27N5O3 (445.2114)


   

2-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine butanedioic acid

2-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine butanedioic acid

C22H24ClN3O5 (445.1404)


   

(2R,3R,3aS,9bS)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-2-(morpholine-4-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one

(2R,3R,3aS,9bS)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-2-(morpholine-4-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one

C23H25F2N3O4 (445.1813)


   

(1R,9S,10S,11S)-10-(hydroxymethyl)-5-(4-methoxyphenyl)-12-methyl-6-oxo-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1R,9S,10S,11S)-10-(hydroxymethyl)-5-(4-methoxyphenyl)-12-methyl-6-oxo-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C26H27N3O4 (445.2001)


   

(2S,3S,3aR,9bR)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-2-[4-morpholinyl(oxo)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one

(2S,3S,3aR,9bR)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-2-[4-morpholinyl(oxo)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one

C23H25F2N3O4 (445.1813)


   

(3R)-3-(2-hydroxyethyl)-N,N-dimethyl-2-(1-oxopropyl)-4-[3-(5-pyrimidinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

(3R)-3-(2-hydroxyethyl)-N,N-dimethyl-2-(1-oxopropyl)-4-[3-(5-pyrimidinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C25H27N5O3 (445.2114)


   

(1S,9R,10R,11R)-10-(hydroxymethyl)-5-(4-methoxyphenyl)-12-methyl-6-oxo-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1S,9R,10R,11R)-10-(hydroxymethyl)-5-(4-methoxyphenyl)-12-methyl-6-oxo-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C26H27N3O4 (445.2001)


   

[(2S,3S)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]-pyridin-2-ylmethanone

[(2S,3S)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]-pyridin-2-ylmethanone

C24H26F3N3O2 (445.1977)


   

2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-[[oxo(5-thiazolyl)methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester

2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-[[oxo(5-thiazolyl)methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester

C21H23N3O6S (445.1307)


   

[(2R,3R)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]-pyridin-2-ylmethanone

[(2R,3R)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]-pyridin-2-ylmethanone

C24H26F3N3O2 (445.1977)


   
   
   
   

(1S,19S)-9,9,16,16-tetramethyl-14-oxido-8-oxa-23,25-diaza-14-azoniaheptacyclo[17.5.2.01,17.03,15.04,13.07,12.019,23]hexacosa-2,4(13),5,7(12),10,14-hexaene-24,26-dione

(1S,19S)-9,9,16,16-tetramethyl-14-oxido-8-oxa-23,25-diaza-14-azoniaheptacyclo[17.5.2.01,17.03,15.04,13.07,12.019,23]hexacosa-2,4(13),5,7(12),10,14-hexaene-24,26-dione

C26H27N3O4 (445.2001)


   

4-chloro-N-[(2S)-3-(1H-indol-3-yl)-1-oxo-1-piperidin-1-ylpropan-2-yl]benzenesulfonamide

4-chloro-N-[(2S)-3-(1H-indol-3-yl)-1-oxo-1-piperidin-1-ylpropan-2-yl]benzenesulfonamide

C22H24ClN3O3S (445.1227)


   

(1S,3S,12Z)-1-hydroxy-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.018,23]hexacosa-8,12,15,17(26),18(23),19,24-heptaene-4,10-dione

(1S,3S,12Z)-1-hydroxy-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.018,23]hexacosa-8,12,15,17(26),18(23),19,24-heptaene-4,10-dione

C26H27N3O4 (445.2001)


   

(6S)-5,6,7,8-Tetrahydrofolate

(6S)-5,6,7,8-Tetrahydrofolate

C19H23N7O6 (445.171)


   

icas#3

icas#3

C24H31NO7 (445.21)


A 4-O-(1H-indol-3-ylcarbonyl)ascaroside derived from (2E,8R)-8-hydroxynon-2-enoic acid. It is a metabolite of the nematode Caenorhabditis elegans.

   

estrone 3-O-(beta-D-glucuronide)(1-)

estrone 3-O-(beta-D-glucuronide)(1-)

C24H29O8 (445.1862)


A steroid glucuronide anion that is the conjugate base of estrone 3-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

(6S)-5,6,7,8-tetrahydrofolic acid

(6S)-5,6,7,8-tetrahydrofolic acid

C19H23N7O6 (445.171)


A derivative of folic acid in which the pteridine ring is fully reduced; it is the parent compound of a variety of coenzymes that serve as carriers of one-carbon groups in metabolic reactions.

   
   
   

ST 21:6;O6;Gly

ST 21:6;O6;Gly

C23H27NO8 (445.1737)


   

ST 22:5;O5;Gly

ST 22:5;O5;Gly

C24H31NO7 (445.21)


   

ST 18:2;O5;Tau

ST 18:2;O5;Tau

C20H31NO8S (445.177)


   
   
   

BPTU

BPTU

C23H22F3N3O3 (445.1613)


BPTU (BMS-646786) is a non-nucleotide P2Y1 receptor allosteric antagonist with antithrombotic activity. BPTU is able to block the P2Y1 receptor located at the neuromuscular junction of the gastrointestinal tract[1][2].

   

PQR620

PQR620

C21H25F2N7O2 (445.2038)


PQR620 is an orally bioavailable and selective brain penetrant inhibitor of mTORC1/2[1]. PQR620 is an orally bioavailable and selective brain penetrant inhibitor of mTORC1/2[1].

   

Quipazine (dimaleate)

Quipazine (dimaleate)

C21H23N3O8 (445.1485)


Quipazine dimaleate is a 5-HT agonist with a Ki value of 1.4 nM for displaces [3H]GR65630 from 5-HT3R in rat. Quipazine dimaleate shows antiviral activity against SARS-CoV-2 with an EC50 of 31.64 μM. Quipazine dimaleate behaves as a 5-HT3R antagonist in peripheral models. Quipazine dimaleate can be used for neurological disease research[1][2][3][4].

   

Samelisant

Samelisant

C21H33Cl2N3O3 (445.1899)


Samelisant (SUVN-G3031) is a potent and selective histamine H3 receptor (H3R) inverse agonist with good brain penetration and oral bioavailability. Samelisant has a similar binding affinity towards human (hH3R; Ki=8.7 nM) and rat (rH3R;Ki=9.8 nM) H3R indicating no inter-species differences. Samelisant can be used for the research of sleep-related disorders[1].

   

2,4-dihydroxy-17-methyl-7-[6-methyl-5-(methylamino)oxan-2-yl]-12,16,18-trioxapentacyclo[8.7.1.0¹,¹⁰.0³,⁸.0¹¹,¹⁵]octadeca-3(8),4,6-triene-9,13-dione

2,4-dihydroxy-17-methyl-7-[6-methyl-5-(methylamino)oxan-2-yl]-12,16,18-trioxapentacyclo[8.7.1.0¹,¹⁰.0³,⁸.0¹¹,¹⁵]octadeca-3(8),4,6-triene-9,13-dione

C23H27NO8 (445.1737)


   

3-[(1s,2s,4ar,6s,8as)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-1,4-dihydroxypyridin-2-one

3-[(1s,2s,4ar,6s,8as)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-1,4-dihydroxypyridin-2-one

C24H31NO7 (445.21)


   

3-[(1s,2s,4ar,6r,8as)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-[(1s,2r,5s,6s)-2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]-1,4-dihydroxypyridin-2-one

3-[(1s,2s,4ar,6r,8as)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-[(1s,2r,5s,6s)-2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]-1,4-dihydroxypyridin-2-one

C24H31NO7 (445.21)


   

5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-3-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-1,4-dihydroxypyridin-2-one

5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-3-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-1,4-dihydroxypyridin-2-one

C24H31NO7 (445.21)


   

(1s,3s)-1-hydroxy-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.0³,¹¹.0⁵,⁹.0¹⁷,²⁶.0¹⁸,²³]hexacosa-8,12,15,17(26),18(23),19,24-heptaene-4,10-dione

(1s,3s)-1-hydroxy-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.0³,¹¹.0⁵,⁹.0¹⁷,²⁶.0¹⁸,²³]hexacosa-8,12,15,17(26),18(23),19,24-heptaene-4,10-dione

C26H27N3O4 (445.2001)


   

(6r,7s)-3-[(acetyloxy)methyl]-7-{[(5s)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6r,7s)-3-[(acetyloxy)methyl]-7-{[(5s)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C17H23N3O9S (445.1155)


   

(1s,9s,10s,13s)-6-[(1r,2r,4as,6r,8ar)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-1,4,10,13-tetrahydroxy-8-oxa-4-azatricyclo[7.3.1.0²,⁷]trideca-2,6-dien-5-one

(1s,9s,10s,13s)-6-[(1r,2r,4as,6r,8ar)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-1,4,10,13-tetrahydroxy-8-oxa-4-azatricyclo[7.3.1.0²,⁷]trideca-2,6-dien-5-one

C24H31NO7 (445.21)


   

1-hydroxy-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.0³,¹¹.0⁵,⁹.0¹⁷,²⁶.0¹⁸,²³]hexacosa-8,12,15,17(26),18(23),19,24-heptaene-4,10-dione

1-hydroxy-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.0³,¹¹.0⁵,⁹.0¹⁷,²⁶.0¹⁸,²³]hexacosa-8,12,15,17(26),18(23),19,24-heptaene-4,10-dione

C26H27N3O4 (445.2001)


   

(2s,9s,9as)-9-hydroxy-9-{[(1r,4r)-3-hydroxy-1-methyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2-methyl-1h,2h,9ah-imidazo[1,2-a]indol-3-one

(2s,9s,9as)-9-hydroxy-9-{[(1r,4r)-3-hydroxy-1-methyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2-methyl-1h,2h,9ah-imidazo[1,2-a]indol-3-one

C24H23N5O4 (445.175)


   

6-[(2r,4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-5-hydroxy-1-[(1r)-1-hydroxyethyl]-3-methylnaphtho[2,3-c]thiophene-4,9-dione

6-[(2r,4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-5-hydroxy-1-[(1r)-1-hydroxyethyl]-3-methylnaphtho[2,3-c]thiophene-4,9-dione

C23H27NO6S (445.1559)


   

(6r,7s)-3-[(acetyloxy)methyl]-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6r,7s)-3-[(acetyloxy)methyl]-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C17H23N3O9S (445.1155)


   

5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-3-(5-hydroxy-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)pyridine-2,4-diol

5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-3-(5-hydroxy-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)pyridine-2,4-diol

C24H31NO7 (445.21)


   

[2-hydroxy-13-methyl-4-(3-methylbutyl)-11,14,17-trioxo-5-oxa-15-thia-13-azatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),2,8,12(16)-tetraen-6-yl]acetic acid

[2-hydroxy-13-methyl-4-(3-methylbutyl)-11,14,17-trioxo-5-oxa-15-thia-13-azatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),2,8,12(16)-tetraen-6-yl]acetic acid

C22H23NO7S (445.1195)


   

6-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-5-hydroxy-1-(1-hydroxyethyl)-3-methylnaphtho[2,3-c]thiophene-4,9-dione

6-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-5-hydroxy-1-(1-hydroxyethyl)-3-methylnaphtho[2,3-c]thiophene-4,9-dione

C23H27NO6S (445.1559)


   

3-[(1s,2s,4ar,6s,8as)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-[(1s,2r,5s,6s)-2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]-1,4-dihydroxypyridin-2-one

3-[(1s,2s,4ar,6s,8as)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-[(1s,2r,5s,6s)-2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]-1,4-dihydroxypyridin-2-one

C24H31NO7 (445.21)


   

3-(aziridin-2-yl)-3,7,8,10,12b-pentahydroxy-9,12-dimethoxy-2,4,4a,5-tetrahydrotetraphene-1,6-dione

3-(aziridin-2-yl)-3,7,8,10,12b-pentahydroxy-9,12-dimethoxy-2,4,4a,5-tetrahydrotetraphene-1,6-dione

C22H23NO9 (445.1373)


   

(2s,9s)-9-hydroxy-9-{[(1r,4r)-3-hydroxy-1-methyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2-methyl-1h,2h,9ah-imidazo[1,2-a]indol-3-one

(2s,9s)-9-hydroxy-9-{[(1r,4r)-3-hydroxy-1-methyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2-methyl-1h,2h,9ah-imidazo[1,2-a]indol-3-one

C24H23N5O4 (445.175)


   

6-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-1,4,10,13-tetrahydroxy-8-oxa-4-azatricyclo[7.3.1.0²,⁷]trideca-2,6-dien-5-one

6-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-1,4,10,13-tetrahydroxy-8-oxa-4-azatricyclo[7.3.1.0²,⁷]trideca-2,6-dien-5-one

C24H31NO7 (445.21)


   

1,5,10,13-tetrahydroxy-8-oxa-4-azatricyclo[7.3.1.0²,⁷]trideca-2(7),3,5-trien-6-yl 2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylate

1,5,10,13-tetrahydroxy-8-oxa-4-azatricyclo[7.3.1.0²,⁷]trideca-2(7),3,5-trien-6-yl 2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylate

C24H31NO7 (445.21)


   

(5r,8s,9r)-8-benzoyl-6,9-dihydroxy-2-[(1s,2s)-1-hydroxy-2-methoxyhex-3-en-1-yl]-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

(5r,8s,9r)-8-benzoyl-6,9-dihydroxy-2-[(1s,2s)-1-hydroxy-2-methoxyhex-3-en-1-yl]-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C23H27NO8 (445.1737)


   

(2e,6e)-8-{2-[(1s)-1-carboxy-2-methylbutyl]-4,6-dihydroxy-1-oxo-3h-isoindol-5-yl}-2,6-dimethylocta-2,6-dienoic acid

(2e,6e)-8-{2-[(1s)-1-carboxy-2-methylbutyl]-4,6-dihydroxy-1-oxo-3h-isoindol-5-yl}-2,6-dimethylocta-2,6-dienoic acid

C24H31NO7 (445.21)


   

(5r,8s,9r)-8-benzoyl-6,9-dihydroxy-2-[(1s,2s,3z)-1-hydroxy-2-methoxyhex-3-en-1-yl]-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

(5r,8s,9r)-8-benzoyl-6,9-dihydroxy-2-[(1s,2s,3z)-1-hydroxy-2-methoxyhex-3-en-1-yl]-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C23H27NO8 (445.1737)


   

8-benzoyl-6,9-dihydroxy-2-(1-hydroxy-2-methoxyhex-3-en-1-yl)-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

8-benzoyl-6,9-dihydroxy-2-(1-hydroxy-2-methoxyhex-3-en-1-yl)-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C23H27NO8 (445.1737)


   

3-[(1r,2r,4as,5s,6r,8ar)-5-hydroxy-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-[(1r,2s,5r,6r)-2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]pyridine-2,4-diol

3-[(1r,2r,4as,5s,6r,8ar)-5-hydroxy-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-[(1r,2s,5r,6r)-2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]pyridine-2,4-diol

C24H31NO7 (445.21)


   

[(4r,6s)-2-hydroxy-13-methyl-4-(3-methylbutyl)-11,14,17-trioxo-5-oxa-15-thia-13-azatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),2,8,12(16)-tetraen-6-yl]acetic acid

[(4r,6s)-2-hydroxy-13-methyl-4-(3-methylbutyl)-11,14,17-trioxo-5-oxa-15-thia-13-azatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),2,8,12(16)-tetraen-6-yl]acetic acid

C22H23NO7S (445.1195)


   

2-({8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-yl}oxy)-6-methyloxane-3,4,5-triol

2-({8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-yl}oxy)-6-methyloxane-3,4,5-triol

C24H31NO7 (445.21)


   

(5r)-5-[(20s)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl]-3-methyl-5h-furan-2-one

(5r)-5-[(20s)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl]-3-methyl-5h-furan-2-one

C26H23NO6 (445.1525)


   

7-hydroxy-2-{[(3r)-11-hydroxy-3,7-dimethyl-2-oxa-6-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-3-yl]methyl}-5-(2-oxopropyl)chromen-4-one

7-hydroxy-2-{[(3r)-11-hydroxy-3,7-dimethyl-2-oxa-6-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-3-yl]methyl}-5-(2-oxopropyl)chromen-4-one

C26H23NO6 (445.1525)


   

(2r)-2-phenyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}ethanimidic acid

(2r)-2-phenyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}ethanimidic acid

C19H27NO11 (445.1584)


   

(2s,3r,4r,5r,6s)-2-{[(9bs,11r)-8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-yl]oxy}-6-methyloxane-3,4,5-triol

(2s,3r,4r,5r,6s)-2-{[(9bs,11r)-8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-yl]oxy}-6-methyloxane-3,4,5-triol

C24H31NO7 (445.21)


   

(1s,17r,19r)-26-hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaene-2,24-dione

(1s,17r,19r)-26-hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaene-2,24-dione

C26H27N3O4 (445.2001)


   

5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-3-[6-(hydroxymethyl)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]pyridine-2,4-diol

5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-3-[6-(hydroxymethyl)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]pyridine-2,4-diol

C24H31NO7 (445.21)


   

(3r,4s,5r)-2-[(2s,3s,4r,5r)-2-(6-aminopurin-9-yl)-3,4-dihydroxy-5-(hydroxymethyl)-2-(methylsulfanyl)oxolan-3-yl]oxane-3,4,5-triol

(3r,4s,5r)-2-[(2s,3s,4r,5r)-2-(6-aminopurin-9-yl)-3,4-dihydroxy-5-(hydroxymethyl)-2-(methylsulfanyl)oxolan-3-yl]oxane-3,4,5-triol

C16H23N5O8S (445.1267)


   

3-[(1r,2r,4as,6r,8ar)-6-(hydroxymethyl)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-[(1r,2s,5r,6r)-2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]pyridine-2,4-diol

3-[(1r,2r,4as,6r,8ar)-6-(hydroxymethyl)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-[(1r,2s,5r,6r)-2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]pyridine-2,4-diol

C24H31NO7 (445.21)


   

26-hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaene-2,24-dione

26-hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaene-2,24-dione

C26H27N3O4 (445.2001)


   

(3r,4as,12br)-3-[(2s)-aziridin-2-yl]-3,7,8,10,12b-pentahydroxy-9,12-dimethoxy-2,4,4a,5-tetrahydrotetraphene-1,6-dione

(3r,4as,12br)-3-[(2s)-aziridin-2-yl]-3,7,8,10,12b-pentahydroxy-9,12-dimethoxy-2,4,4a,5-tetrahydrotetraphene-1,6-dione

C22H23NO9 (445.1373)


   

(1r,17s,19s)-26-hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaene-2,24-dione

(1r,17s,19s)-26-hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaene-2,24-dione

C26H27N3O4 (445.2001)


   

9-[5-(dimethylamino)-6-methyloxan-2-yl]-1,8-dihydroxy-3-methyltetraphene-7,12-dione

9-[5-(dimethylamino)-6-methyloxan-2-yl]-1,8-dihydroxy-3-methyltetraphene-7,12-dione

C27H27NO5 (445.1889)


   

(17s)-11-(acetyloxy)-5-methoxy-16-methyl-8-oxo-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraen-4-yl 3-hydroxybutanoate

(17s)-11-(acetyloxy)-5-methoxy-16-methyl-8-oxo-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraen-4-yl 3-hydroxybutanoate

C23H27NO8 (445.1737)


   

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3s)-2-hydroxy-3-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2-isopropylbutanoate

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3s)-2-hydroxy-3-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2-isopropylbutanoate

C24H31NO7 (445.21)


   

(2s,11s,15r,17r)-2,4-dihydroxy-17-methyl-7-[(2r,5s,6r)-6-methyl-5-(methylamino)oxan-2-yl]-12,16,18-trioxapentacyclo[8.7.1.0¹,¹⁰.0³,⁸.0¹¹,¹⁵]octadeca-3(8),4,6-triene-9,13-dione

(2s,11s,15r,17r)-2,4-dihydroxy-17-methyl-7-[(2r,5s,6r)-6-methyl-5-(methylamino)oxan-2-yl]-12,16,18-trioxapentacyclo[8.7.1.0¹,¹⁰.0³,⁸.0¹¹,¹⁵]octadeca-3(8),4,6-triene-9,13-dione

C23H27NO8 (445.1737)


   

3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-(naphthalen-2-yl)-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-(naphthalen-2-yl)-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C30H23NO3 (445.1678)


   

(2s,9s,9as)-9-hydroxy-9-{[(1s,4r)-3-hydroxy-1-methyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2-methyl-1h,2h,9ah-imidazo[1,2-a]indol-3-one

(2s,9s,9as)-9-hydroxy-9-{[(1s,4r)-3-hydroxy-1-methyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2-methyl-1h,2h,9ah-imidazo[1,2-a]indol-3-one

C24H23N5O4 (445.175)


   

(1s,17s,19r)-26-hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaene-2,24-dione

(1s,17s,19r)-26-hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaene-2,24-dione

C26H27N3O4 (445.2001)


   

3-[(acetyloxy)methyl]-7-[(5-amino-5-carboxy-1-hydroxypentylidene)amino]-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

3-[(acetyloxy)methyl]-7-[(5-amino-5-carboxy-1-hydroxypentylidene)amino]-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C17H23N3O9S (445.1155)


   

(1r,9s,10s,13s)-1,5,10,13-tetrahydroxy-8-oxa-4-azatricyclo[7.3.1.0²,⁷]trideca-2(7),3,5-trien-6-yl (1r,2r,4as,6r,8ar)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylate

(1r,9s,10s,13s)-1,5,10,13-tetrahydroxy-8-oxa-4-azatricyclo[7.3.1.0²,⁷]trideca-2(7),3,5-trien-6-yl (1r,2r,4as,6r,8ar)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylate

C24H31NO7 (445.21)


   

(17s)-26-hydroxy-9,9,16,16-tetramethyl-24-oxo-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-2,4(13),5,7(12),10,14,25-heptaen-14-ium-14-olate

(17s)-26-hydroxy-9,9,16,16-tetramethyl-24-oxo-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-2,4(13),5,7(12),10,14,25-heptaen-14-ium-14-olate

C26H27N3O4 (445.2001)


   

9-[(2r,5s,6s)-5-(dimethylamino)-6-methyloxan-2-yl]-1,8-dihydroxy-3-methyltetraphene-7,12-dione

9-[(2r,5s,6s)-5-(dimethylamino)-6-methyloxan-2-yl]-1,8-dihydroxy-3-methyltetraphene-7,12-dione

C27H27NO5 (445.1889)


   

8-[2-(1-carboxy-2-methylbutyl)-4,6-dihydroxy-1-oxo-3h-isoindol-5-yl]-2,6-dimethylocta-2,6-dienoic acid

8-[2-(1-carboxy-2-methylbutyl)-4,6-dihydroxy-1-oxo-3h-isoindol-5-yl]-2,6-dimethylocta-2,6-dienoic acid

C24H31NO7 (445.21)


   

5-{17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl}-3-methyl-5h-furan-2-one

5-{17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl}-3-methyl-5h-furan-2-one

C26H23NO6 (445.1525)


   

2,5-dimethyl 3,4-bis(5-hydroxy-1h-indol-3-yl)-1h-pyrrole-2,5-dicarboxylate

2,5-dimethyl 3,4-bis(5-hydroxy-1h-indol-3-yl)-1h-pyrrole-2,5-dicarboxylate

C24H19N3O6 (445.1274)


   

(1s,10s,11s)-11-(acetyloxy)-5-methoxy-16-methyl-8-oxo-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraen-4-yl 3-hydroxybutanoate

(1s,10s,11s)-11-(acetyloxy)-5-methoxy-16-methyl-8-oxo-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraen-4-yl 3-hydroxybutanoate

C23H27NO8 (445.1737)